Aubagio ‘slows brain atrophy in RRMS patients’
Aubagio ‘slows brain atrophy in RRMS patients’
Genzyme has announced results from magnetic resonance imaging (MRI) analysis of participants in the Phase III TEMSO clinical trial showing Aubagio was able to slow the loss of brain volume (or atrophy) versus a placebo over two years in patients with relapsing-remitting multiple sclerosis (RRMS)... Read More - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 12352 Views
-
Last post by accordingnature495
-
- 0 Replies
- 1912 Views
-
Last post by NHE
-
- 0 Replies
- 1627 Views
-
Last post by NHE
-
- 4 Replies
- 1568 Views
-
Last post by NHE
-
- 0 Replies
- 1262 Views
-
Last post by NHE
-
- 0 Replies
- 1611 Views
-
Last post by NHE
-
- 0 Replies
- 2066 Views
-
Last post by frodo
-
- 0 Replies
- 2169 Views
-
Last post by NHE
-
- 0 Replies
- 1727 Views
-
Last post by NHE